Zanosar

From WikiMD.org
Jump to navigation Jump to search

Zanosar

Zanosar (/zænəsɑːr/), also known as streptozocin, is a chemotherapy drug that is primarily used to treat pancreatic cancer. It is a naturally occurring alkylating agent derived from Streptomyces achromogenes, a strain of soil bacteria.

Etymology

The name "Zanosar" is a brand name, while "streptozocin" is derived from the name of the bacteria from which it is isolated, Streptomyces achromogenes. The suffix "-zin" is common in drugs that are alkylating agents.

Usage

Zanosar is used in the treatment of islet cell carcinoma, a rare type of pancreatic cancer. It works by damaging the DNA of cancer cells, which prevents them from dividing and growing. Zanosar is administered intravenously.

Side Effects

Common side effects of Zanosar include nausea, vomiting, and loss of appetite. More serious side effects can include kidney damage and a decrease in blood cells, which can lead to an increased risk of infection, anemia, and bleeding.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski